The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy
World Journal of Urology Jan 31, 2020
Sebben M, Tafuri A, Shakir A, et al. - Researchers sought to assess the factors correlated with the risk of hospital readmission after robot-assisted radical prostatectomy (RARP) with or without extended pelvic lymph node dissection (ePLND) for prostate cancer (PCA) over a long term. In this study, 890 individuals who underwent RARP; ePLND was conducted in 495 of these individuals between January 2013 and December 2018. They analyzed the risk of readmission by clinical, pathological, and perioperative factors. The procedures were performed by skilled and experienced surgeons. For six months, individuals were followed for complications and hospital readmission. They used the logistic regression model and Cox’s proportional hazards to evaluate the correlation of factors with the risk of readmission. The risk of hospital readmission is correlated with ePLND over the long term after RARP for PCA. In individuals who experienced RARP and ePLND, 4.4% of them had readmission, correlated with RARP alone, in which only 0.8% of cases had readmission. They demonstrated that individuals should be informed of the increased risk of hospital readmission when ePLND is organized for staging pelvic lymph nodes.Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
55 lakhs+ doctors trust M3 globally
Unlimited access to original articles by experts
Secure: we never sell your data
Signing up takes less than 2 mins